AKEBIA THERAPEUTICS INC's ticker is AKBA and the CUSIP is 00972D105. A total of 94 filers reported holding AKEBIA THERAPEUTICS INC in Q2 2016. The put-call ratio across all filers is 1.36 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $5,000 | 0.0% | 15,465 | +8.2% | 0.00% | – |
Q2 2022 | $5,000 | -86.1% | 14,293 | -71.9% | 0.00% | – |
Q1 2022 | $36,000 | -74.6% | 50,807 | -19.0% | 0.00% | – |
Q4 2021 | $142,000 | -17.4% | 62,741 | +5.2% | 0.00% | – |
Q3 2021 | $172,000 | -35.3% | 59,634 | -15.1% | 0.00% | -100.0% |
Q2 2021 | $266,000 | +31.7% | 70,222 | +17.9% | 0.00% | 0.0% |
Q1 2021 | $202,000 | +33.8% | 59,537 | +10.2% | 0.00% | 0.0% |
Q4 2020 | $151,000 | +48.0% | 54,036 | +32.9% | 0.00% | – |
Q3 2020 | $102,000 | -81.4% | 40,648 | +0.9% | 0.00% | -100.0% |
Q2 2020 | $547,000 | +209.0% | 40,300 | +73.0% | 0.00% | +200.0% |
Q1 2020 | $177,000 | -33.0% | 23,299 | -44.2% | 0.00% | 0.0% |
Q4 2019 | $264,000 | +47.5% | 41,725 | -8.5% | 0.00% | 0.0% |
Q3 2019 | $179,000 | -15.2% | 45,626 | +4.9% | 0.00% | 0.0% |
Q2 2019 | $211,000 | -47.2% | 43,495 | -11.0% | 0.00% | -50.0% |
Q1 2019 | $400,000 | +154.8% | 48,846 | +72.3% | 0.00% | +100.0% |
Q4 2018 | $157,000 | -39.6% | 28,349 | -3.7% | 0.00% | -50.0% |
Q3 2018 | $260,000 | -14.8% | 29,428 | -3.7% | 0.00% | 0.0% |
Q2 2018 | $305,000 | +16.0% | 30,548 | +10.8% | 0.00% | 0.0% |
Q1 2018 | $263,000 | -44.9% | 27,576 | -14.1% | 0.00% | -33.3% |
Q4 2017 | $477,000 | -18.2% | 32,110 | +8.4% | 0.00% | -40.0% |
Q3 2017 | $583,000 | +75.1% | 29,632 | +27.7% | 0.01% | +66.7% |
Q2 2017 | $333,000 | +47.3% | 23,208 | -5.6% | 0.00% | +50.0% |
Q1 2017 | $226,000 | -30.2% | 24,593 | -20.9% | 0.00% | -50.0% |
Q4 2016 | $324,000 | +30.1% | 31,092 | +13.0% | 0.00% | +33.3% |
Q3 2016 | $249,000 | +2.0% | 27,519 | -15.8% | 0.00% | 0.0% |
Q2 2016 | $244,000 | -15.0% | 32,665 | +2.6% | 0.00% | -25.0% |
Q1 2016 | $287,000 | -21.8% | 31,834 | +12.1% | 0.00% | 0.0% |
Q4 2015 | $367,000 | +56.2% | 28,405 | +16.6% | 0.00% | +33.3% |
Q3 2015 | $235,000 | -12.6% | 24,353 | -6.8% | 0.00% | -25.0% |
Q2 2015 | $269,000 | +35.2% | 26,119 | +45.9% | 0.00% | +100.0% |
Q1 2015 | $199,000 | +13.1% | 17,902 | +18.1% | 0.00% | 0.0% |
Q4 2014 | $176,000 | – | 15,152 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Alerce Investment Management, L.P. | 4,652,561 | $1,471,000 | 1.42% |
Orchard Capital Management, LLC | 251,826 | $80,000 | 0.03% |
GSA CAPITAL PARTNERS LLP | 486,568 | $154,000 | 0.02% |
Icon Wealth Advisors, LLC | 400,132 | $127 | 0.02% |
ACADIAN ASSET MANAGEMENT LLC | 7,483,053 | $2,365,000 | 0.01% |
JACOBS LEVY EQUITY MANAGEMENT, INC | 2,042,816 | $646,000 | 0.01% |
WIPFLI FINANCIAL ADVISORS LLC, | 200,000 | $63,000 | 0.00% |
WEALTH EFFECTS LLC | 18,316 | $6,000 | 0.00% |
James J. Burns & Company, LLC | 25,142 | $8,000 | 0.00% |
Bayesian Capital Management, LP | 68,600 | $22,000 | 0.00% |